Within APERIM a transdisciplinary network of leading experts in bioinformatics and cancer immunology is working on practical implementation of immunotherapies targeting unique tumor mutations. Partners will develop user-friendly software modules as well as analytical standard operating procedures for clinical use, and apply the bioinformatics platform in clinical settings.

APERIM, which stands for ‘Advanced bioinformatics platform for PERsonalized cancer IMmunotherapy’, started on May 2015 as an H2020-funded project and is coordinated by the Medical University of Innsbruck, Austria. The bioinformatics platform aims to accelerate the clinical translation and maximize the accessibility and utility of biomedical data in research and medicine.